Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Canntab Therapeutics appoints pharmaceutical scientist as new CSO

Joshi Laxminarayan's expertise includes areas such as nano emulsion, extended release, and poorly soluble drug development Laxminarayan previously act...

Canntab Therapeutics secures final tranche of C$3.7M private placement

The last tranche raised C$645,000 by offering nearly 1.3 million units at a price of $0.50 per unit Canntab has filed 13 patents in Canada and the US ...

Canntab Therapeutics nominates Canadian pharmaceutical executive Larry Latowsky as executive chairman

The incoming chairman previously served as the CEO of Katz Group Canada, which owns and operated a network of leading pharmacies across Canada The app...

Canntab Therapeutics raised 3 million dollars and receives final Health Canada Licence

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from...

Canntab Therapeutics awarded processing and sales license from Health Canada

The company is getting ready to move into full-scale manufacturing of its cannabinoid pills The company plans to roll out new brands and products for ...

Canntab Therapeutics granted cannabis research licence from Health Canada

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics Limited (CSE:PILL-OTCQB: CTABF) Co-Founder and CFO Richard Goldstein joi...

Canntab awarded Health Canada cannabis research licence

It marks the final step to obtain a standard processing licence and sale for medical purposes licence Canntab’s facility in Markham, Ontario, is equip...

Canntab Therapeutics announces plans to raise C$2.5 million to fund expansion efforts

CEO Jeffrey Renwick said the firm is 'on the doorstep' of full-scale manufacturing of medical cannabis in pill form. The firm is launching a private p...

Canntab Therapeutics submits Site Evidence Package to Health Canada for Licence Producer Status approval

It marks the final step to obtain a licence to process cannabis at the facility, pending Health Canada review and approval Jeff Renwick, co-founder an...

Exactus and Canntab team up to produce and sell hemp-derived cannabinoid tablets

Canntab will manufacture its hard pill formulations (made from CBD and other hemp derivatives) in a Florida facility operated by Exactus, using equipm...

Canntab Therapeutics sign supply and distribution agreement with Exactus in U.S.

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL-OTCQBCTABF) CFO Richard Goldstein joined Steve Darling on Sky...

Canntab sign deal with World Class Extractions to use the “Boss” machine

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL) CFO Richard Goldstein sat down with Steve Darling from Proac...

Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement

What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada sank 3.7% to 141.07 points. ...

Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement

Canntab's shares flew after it announced it is teaming up with World Class Extractions to process cannabis derivatives Also on the move was Lexaria Bi...

Canntab Therapeutics teams up with World Class Extractions to process and manufacture CBD pills

The two companies are establishing a joint venture that will see World Class Extractions install its cannabis extraction and processing systems for Ca...

Canntab receives indication of patentability for its release cannabidiol formulation

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE:PILL.CN-OTCQX: CTABF) Chief Financial Officer Richard Goldstein joi...

Canntab's plans boosted by initial indication of patentability for its immediate release CBD formulation

Canntab has successfully created a line of patent-pending precision oral delivery hard tablets Canntab has filed 13 patents in Canada and the United S...

Cannabis pill developer Canntab Therapeutics making solid progress in bringing its products to market

Only company in North America to have developed a product line of hard pills for a variety of cannabinoid and terpenoid blendsExpecting near term reve...

Canntab Therapeutics making final steps towards bringing its products to market

The group said it would start manufacturing commercial batches of oil-filled gel capsules at its facility in Ontario and request Health Canada approva...

Canntab Therapeutics hoping to bring their slow release tablet tech to U.S.

What are you searching for? viewCanntab Therapeutics Ltd CannTab Therapeutics () CEO Jeff Renwick and Chief Financial officer Richard Goldstein sat do...


MjInvest.com